The AI4Leprosy diagnostic tool was officially launched in February 2022. It was developed through a collaborative partnership between the Novartis Foundation, Microsoft’s AI for Health team, and the Oswaldo Cruz Foundation (Fiocruz).
To achieve this, the project collected skin lesion images and patient data between 2018 and 2020 at a clinic in Rio de Janeiro, Brazil. The resulting AI model helps health workers and clinicians identify suspected leprosy lesions more quickly and accurately.